| Galecto, Inc. (GLTO) | 8.90% | $41.94M | N/A | N/A | N/A |
| Cypherpunk Technologies, Inc. (LPTX) | 3.36% | $67.98M | N/A | N/A | N/A |
| Mersana Therapeutics, Inc. (MRSN) | 3.21% | $142.91M | -12.61% | 99.25% | -0.48 |
| Cidara Therapeutics, Inc. (CDTX) | 2.61% | $6.92B | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD) | 2.32% | $319.73M | N/A | N/A | N/A |
| Kodiak Sciences, Inc. (KOD) | 1.97% | $1.22B | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX) | 1.70% | $699.77M | -82.16% | 97.75% | 3.42 |
| Minerva Neurosciences, Inc. (NERV) | 1.63% | $28.25M | N/A | N/A | N/A |
| AlloVir, Inc. (ALVR) | 1.54% | $158.97M | N/A | N/A | N/A |
| Astria Therapeutics, Inc. (ATXS) | 1.50% | $737.54M | N/A | N/A | 416.92 |
| Axogen, Inc. (AXGN) | 1.42% | $1.37B | 23.51% | 76.55% | 4.21 |
| Verrica Pharmaceuticals, Inc. (VRCA) | 1.41% | $71.74M | N/A | 92.27% | 1.80 |
| Annexon, Inc. (ANNX) | 1.41% | $710.62M | N/A | N/A | N/A |
| Annovis Bio, Inc. (ANVS) | 1.34% | $100.18M | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS) | 1.34% | $124.78M | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE) | 1.31% | $530.26M | 29.89% | 77.39% | 3.72 |
| Achieve Life Sciences, Inc. (ACHV) | 1.31% | $239.02M | N/A | N/A | N/A |
| Trevi Therapeutics, Inc. (TRVI) | 1.27% | $1.62B | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA) | 1.22% | $129.42M | -91.41% | 96.67% | 1.57 |
| Vanda Pharmaceuticals, Inc. (VNDA) | 1.21% | $391.81M | 18.06% | 91.63% | 0.06 |
| Vistagen Therapeutics, Inc. (VTGN) | 1.21% | $173.39M | 40.98% | 28.29% | 106.17 |
| Esperion Therapeutics, Inc. (ESPR) | 1.17% | $903.66M | 69.10% | 52.71% | 3.41 |
| SOPHiA GENETICS SA (SOPH) | 1.17% | $320.24M | 22.77% | 66.32% | 4.15 |
| Assembly Biosciences, Inc. (ASMB) | 1.16% | $547.27M | 57.62% | 99.70% | 2.55 |
| Sol-Gel Technologies Ltd. (SLGL) | 1.15% | $119.15M | -92.54% | N/A | 3.24 |
| Opus Genetics, Inc. (OCUP) | 1.15% | $146.89M | -20.38% | 99.58% | 5.93 |
| Galectin Therapeutics, Inc. (GALT) | 1.12% | $419.76M | N/A | N/A | N/A |
| Mind Medicine (MindMed), Inc. (MNMD) | 1.10% | $1.19B | N/A | N/A | N/A |
| AC Immune SA (ACIU) | 1.09% | $320.58M | -96.01% | N/A | 31.27 |
| Oramed Pharmaceuticals, Inc. (ORMP) | 1.08% | $122.59M | N/A | N/A | -10.93 |
| KalVista Pharmaceuticals, Inc. (KALV) | 1.06% | $854.23M | N/A | 91.00% | 41.65 |
| DiaMedica Therapeutics, Inc. (DMAC) | 1.04% | $451.51M | N/A | N/A | N/A |
| SELLAS Life Sciences Group, Inc. (SLS) | 1.03% | $290.58M | N/A | N/A | N/A |
| Karyopharm Therapeutics, Inc. (KPTI) | 1.02% | $114.41M | 13.57% | 94.93% | 1.45 |
| ADC Therapeutics SA (ADCT) | 1.01% | $521.52M | -11.03% | 91.95% | 10.22 |
| Whitehawk Therapeutics, Inc. (AADI) | 1.01% | $111.22M | -100.00% | N/A | -2.16 |
| Rigel Pharmaceuticals, Inc. (RIGL) | 1.01% | $771.07M | 25.59% | 93.16% | 1.65 |
| MediciNova, Inc. (MNOV) | 0.98% | $74.70M | N/A | -31.59% | 116.24 |
| VYNE Therapeutics, Inc. (VYNE) | 0.97% | $11.98M | 39.67% | 96.45% | -35.04 |
| Cardiff Oncology, Inc. (CRDF) | 0.97% | $162.34M | -27.27% | -86.67% | 156.07 |
| Neoleukin Therapeutics, Inc. (NLTX) | 0.96% | $299.35M | N/A | N/A | N/A |
| Ocular Therapeutix, Inc. (OCUL) | 0.96% | $3.02B | -5.71% | 87.80% | 33.74 |
| ProQR Therapeutics NV (PRQR) | 0.96% | $257.77M | -20.23% | 76.72% | 6.80 |
| Spero Therapeutics, Inc. (SPRO) | 0.94% | $129.02M | -61.02% | N/A | 2.07 |
| Cognition Therapeutics, Inc. (CGTX) | 0.94% | $141.24M | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO) | 0.92% | $84.60M | 13.77% | 80.40% | 1.27 |
| Solid Biosciences, Inc. (SLDB) | 0.92% | $444.87M | N/A | N/A | N/A |
| Lifeward Ltd. (RWLK) | 0.91% | $11.37M | 1.09% | 43.70% | 0.39 |
| Atea Pharmaceuticals, Inc. (AVIR) | 0.90% | $246.10M | N/A | N/A | N/A |
| Daré Bioscience, Inc. (DARE) | 0.89% | $32.58M | -94.57% | -26,993.90% | 1,213.62 |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 0.85% | $446.98M | 710.40% | 98.86% | 6.20 |
| Ocugen, Inc. (OCGN) | 0.85% | $431.00M | 54.23% | 45.78% | 92.35 |
| Verastem, Inc. (VSTM) | 0.84% | $698.21M | N/A | 82.57% | 44.68 |
| GlycoMimetics, Inc. (GLYC) | 0.84% | $183.52M | N/A | N/A | N/A |
| Voyager Therapeutics, Inc. (VYGR) | 0.84% | $242.42M | -45.73% | 93.03% | 3.32 |
| Precigen, Inc. (PGEN) | 0.84% | $1.35B | 206.61% | 53.70% | 156.55 |
| CorMedix, Inc. (CRMD) | 0.83% | $892.68M | 810.22% | 89.26% | 4.44 |
| Actinium Pharmaceuticals, Inc. (ATNM) | 0.83% | $49.60M | N/A | -128.89% | -25.94 |
| Precision BioSciences, Inc. (DTIL) | 0.83% | $115.54M | -97.74% | -5,084.62% | 70.91 |
| Inovio Pharmaceuticals, Inc. (INO) | 0.81% | $155.27M | N/A | N/A | 445.83 |
| Anixa Biosciences, Inc. (ANIX) | 0.81% | $107.31M | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR) | 0.80% | $1.08B | -51.13% | 98.34% | 15.57 |
| electroCore, Inc. (ECOR) | 0.79% | $38.14M | 32.58% | 85.97% | 1.32 |
| Vivani Medical, Inc. (EYES) | 0.79% | $98.49M | N/A | N/A | N/A |
| Abeona Therapeutics, Inc. (ABEO) | 0.78% | $275.29M | N/A | N/A | 257.63 |
| Larimar Therapeutics, Inc. (LRMR) | 0.77% | $335.51M | N/A | N/A | N/A |
| XBiotech, Inc. (XBIT) | 0.77% | $77.13M | N/A | N/A | N/A |
| PMV Pharmaceuticals, Inc. (PMVP) | 0.76% | $63.85M | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH) | 0.72% | $355.96M | 83.60% | 87.24% | 4.30 |
| PDS Biotechnology Corp. (PDSB) | 0.72% | $50.27M | N/A | N/A | N/A |
| IRIDEX Corp. (IRIX) | 0.69% | $16.96M | 7.80% | 32.15% | 0.49 |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.68% | $0.01M | -33.23% | N/A | 14.41 |
| Enlivex Therapeutics Ltd. (ENLV) | 0.68% | $20.92M | N/A | N/A | N/A |
| Aldeyra Therapeutics, Inc. (ALDX) | 0.67% | $240.05M | N/A | N/A | N/A |
| InspireMD, Inc. (NSPR) | 0.67% | $83.47M | 39.39% | 34.24% | 15.04 |
| BioVie, Inc. (BIVI) | 0.64% | $10.78M | N/A | N/A | N/A |
| InflaRx NV (IFRX) | 0.62% | $67.13M | -79.53% | -320.17% | 220.06 |
| aTyr Pharma, Inc. (LIFE) | 0.61% | $71.86M | N/A | -104.74% | -41.83 |
| Exagen, Inc. (XGN) | 0.61% | $159.32M | 37.87% | 58.43% | 3.85 |
| Immunic, Inc. (IMUX) | 0.60% | $73.82M | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA) | 0.60% | $452.58M | -73.83% | 61.75% | 2.81 |
| Curis, Inc. (CRIS) | 0.58% | $15.39M | 8.36% | 98.52% | 4.08 |
| CollPlant Biotechnologies Ltd. (CLGN) | 0.55% | $21.24M | 1,825.00% | -538.96% | 11.45 |
| Immuneering Corp. (IMRX) | 0.52% | $373.21M | N/A | N/A | N/A |
| Lyra Therapeutics, Inc. (LYRA) | 0.51% | $6.98M | -87.18% | -300.00% | 34.77 |
| Cellectar Biosciences, Inc. (CLRB) | 0.51% | $13.57M | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX) | 0.48% | $26.76M | -49.39% | N/A | 0.92 |
| Akebia Therapeutics, Inc. (AKBA) | 0.48% | $427.24M | 57.01% | 83.49% | 3.53 |
| Tempest Therapeutics, Inc. (TPST) | 0.25% | $14.49M | N/A | N/A | N/A |
| Carisma Therapeutics, Inc. (SESN) | 0.16% | $1.99M | 1,236.78% | N/A | 0.18 |
| CARA Therapeutics, Inc. (CARA) | 0.10% | $39.58M | -100.00% | N/A | 81.81 |